Entrada Therapeutics reported cash from operations of -$32.46M and free cash flow of -$32.47M for the quarter ended Jun 2026, down 10.1% year over year. This cash flow statement covers 24 quarters of results from Sep 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||
| Net Income | -14.43M | -18.45M | -21.67M | -23.18M | -25.14M | -24.63M | -6.72M | -25.93M | 35.46M | -9.50M | 23.50M | 54.99M | -13.99M | 1.10M | -17.35M | -43.10M | -44.18M | -39.16M | -39.72M | -42.76M | ||||
| Share-based Compensation | 0.58M | 1.46M | 32.99M | -28.68M | 2.71M | 2.88M | 2.75M | 74.83M | 3.73M | 4.62M | 4.86M | 4.70M | 5.09M | 5.05M | 5.12M | 4.36M | 4.74M | 5.15M | ||||||
| Deferred Taxes | -0.22M | 0.06M | ||||||||||||||||||||||
| Cash from Operations | -14.07M | -20.54M | -20.99M | -18.01M | -27.48M | -27.30M | 203.40M | -35.09M | -24.49M | -4.01M | -25.52M | 39.83M | -24.27M | -31.61M | -38.51M | -29.49M | -28.31M | -32.20M | -41.70M | -32.46M | ||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||
| Amortizatization of Intangibles | -0.14M | -0.14M | 0.03M | 0.10M | 0.24M | 1.69M | 1.85M | 2.00M | 2.04M | 2.26M | 3.21M | 2.51M | 1.34M | 0.96M | 0.74M | 0.63M | 0.55M | 0.45M | ||||||
| Change in Working Capital | ||||||||||||||||||||||||
| Change in Account Payables | 0.08M | -1.03M | 2.06M | 1.54M | -2.91M | 4.59M | 0.53M | -4.38M | -1.36M | 2.41M | -0.66M | -0.89M | -0.31M | 2.85M | -1.91M | -0.32M | 1.31M | -0.88M | 0.64M | 0.82M | ||||
| Change in Accured Expenses | 2.06M | 1.82M | -1.53M | 0.73M | 6.90M | -4.34M | 4.11M | -5.05M | 2.80M | 1.96M | -2.52M | 1.62M | 3.04M | -0.42M | -5.46M | 4.31M | 3.74M | 2.15M | -5.95M | 1.27M | ||||
| Change in Taxes | 7.36M | -7.36M | 4.02M | 1.83M | -1.74M | -1.86M | -1.58M | 0.14M | -0.80M | 0.62M | -0.62M | |||||||||||||
| Other Working Capital Changes | 0.66M | 6.28M | 1.67M | -5.14M | 15.49M | 2.00M | 211.58M | -14.43M | -38.21M | -18.97M | 17.89M | -87.02M | -16.97M | -33.72M | -18.51M | -0.77M | -0.42M | -0.12M | 2.46M | -4.85M | ||||
| Investing Activities | ||||||||||||||||||||||||
| Capital Expenditures | 0.81M | 1.32M | 0.59M | 0.78M | 0.81M | 2.16M | 8.63M | 0.68M | 2.44M | -0.19M | 0.84M | -2.88M | 4.57M | 0.64M | 1.14M | 0.28M | -0.17M | -0.21M | 0.04M | 0.01M | ||||
| Change in Acquisitions & Divestments | 1.71M | 25.00M | 30.00M | 19.50M | 63.00M | 28.39M | 74.50M | 108.54M | 123.92M | 87.36M | 83.31M | 118.50M | 85.95M | 50.63M | 75.50M | 47.38M | 38.86M | 58.88M | ||||||
| Cash from Investing Activities | -0.81M | -1.32M | -181.53M | 24.23M | -10.13M | 18.79M | -40.44M | -113.26M | -3.74M | 19.04M | 26.15M | -24.38M | -82.93M | 53.37M | 4.78M | 33.80M | 49.11M | 29.12M | 26.99M | 54.95M | ||||
| Financing Activities | ||||||||||||||||||||||||
| Other financing activities | 0.11M | 190.34M | 0.05M | 0.01M | 0.06M | 0.16M | 0.13M | 0.26M | 0.37M | 0.43M | 0.21M | 1.10M | 0.38M | 1.09M | 0.35M | 0.02M | 0.01M | 0.08M | 0.10M | 0.22M | ||||
| Change in Capital Stock | ||||||||||||||||||||||||
| Net Shares Issued and Repurchased | 2.31M | |||||||||||||||||||||||
| Net Equity Issued and Repurchased | 19.41M | 100.00M | -0.39M | |||||||||||||||||||||
| Misc. | ||||||||||||||||||||||||
| Cash from Financing Activities | 0.11M | 190.75M | 0.05M | 0.01M | 0.06M | 0.36M | 19.54M | 0.44M | 0.37M | 0.69M | 0.21M | 101.37M | -0.01M | 1.40M | 0.35M | 0.34M | 0.01M | 0.19M | 0.10M | 0.35M | ||||
| Change in Cash | -14.78M | 168.89M | -202.47M | 6.23M | -37.56M | -8.15M | 182.49M | -147.91M | -27.86M | 15.72M | 0.83M | 116.82M | -107.20M | 23.16M | -33.37M | 4.64M | 20.80M | -2.89M | -14.61M | 22.84M | ||||
| Free Cash Flow | -14.88M | -21.86M | -21.59M | -18.78M | -28.29M | -29.46M | 194.77M | -35.77M | -26.93M | -3.82M | -26.36M | 42.71M | -28.83M | -32.24M | -39.65M | -29.76M | -28.14M | -32.00M | -41.74M | -32.47M | ||||
| Net Cash Flow | -14.78M | 168.89M | -202.47M | 6.23M | -37.56M | -8.15M | 182.49M | -147.91M | -27.86M | 15.72M | 0.83M | 116.82M | -107.20M | 23.16M | -33.37M | 4.64M | 20.80M | -2.89M | -14.61M | 22.84M |